

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.57786733 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.57786733 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.25036636 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.25036636 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.80005971 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.51136130 |
| 7 | exogenous drug catabolic process (GO:0042738) | 6.31357128 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.12453380 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.12453380 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.12453380 |
| 11 | kynurenine metabolic process (GO:0070189) | 6.02260934 |
| 12 | regulation of plasminogen activation (GO:0010755) | 6.01894435 |
| 13 | epoxygenase P450 pathway (GO:0019373) | 5.99842780 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.94684529 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.78907783 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.77067140 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 5.75567796 |
| 18 | urea cycle (GO:0000050) | 5.72173044 |
| 19 | urea metabolic process (GO:0019627) | 5.72173044 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.65248458 |
| 21 | omega-hydroxylase P450 pathway (GO:0097267) | 5.48163393 |
| 22 | regulation of protein activation cascade (GO:2000257) | 5.41813155 |
| 23 | complement activation, alternative pathway (GO:0006957) | 5.37904315 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 5.35262143 |
| 25 | cysteine metabolic process (GO:0006534) | 5.35227089 |
| 26 | intestinal cholesterol absorption (GO:0030299) | 5.31330375 |
| 27 | * negative regulation of fibrinolysis (GO:0051918) | 5.29530151 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 5.25689356 |
| 29 | * regulation of fibrinolysis (GO:0051917) | 5.21371044 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 5.13789867 |
| 31 | bile acid metabolic process (GO:0008206) | 5.10418284 |
| 32 | regulation of cholesterol esterification (GO:0010872) | 5.06321678 |
| 33 | reverse cholesterol transport (GO:0043691) | 5.05080238 |
| 34 | regulation of complement activation (GO:0030449) | 5.03685880 |
| 35 | * protein carboxylation (GO:0018214) | 5.02706693 |
| 36 | * peptidyl-glutamic acid carboxylation (GO:0017187) | 5.02706693 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 4.94691654 |
| 38 | plasma lipoprotein particle remodeling (GO:0034369) | 4.93895568 |
| 39 | protein-lipid complex remodeling (GO:0034368) | 4.93895568 |
| 40 | macromolecular complex remodeling (GO:0034367) | 4.93895568 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.91445008 |
| 42 | regulation of apoptotic cell clearance (GO:2000425) | 4.90446568 |
| 43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.87236163 |
| 44 | negative regulation of protein activation cascade (GO:2000258) | 4.85441983 |
| 45 | tyrosine metabolic process (GO:0006570) | 4.81654312 |
| 46 | homocysteine metabolic process (GO:0050667) | 4.76728205 |
| 47 | phospholipid efflux (GO:0033700) | 4.75172959 |
| 48 | protein-lipid complex subunit organization (GO:0071825) | 4.71579486 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.70119934 |
| 50 | triglyceride homeostasis (GO:0070328) | 4.70119934 |
| 51 | regulation of humoral immune response (GO:0002920) | 4.69338127 |
| 52 | negative regulation of sterol transport (GO:0032372) | 4.65434143 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 4.65434143 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 4.64322175 |
| 55 | amino-acid betaine metabolic process (GO:0006577) | 4.61964321 |
| 56 | * negative regulation of hemostasis (GO:1900047) | 4.60647369 |
| 57 | * negative regulation of blood coagulation (GO:0030195) | 4.60647369 |
| 58 | lysine metabolic process (GO:0006553) | 4.56134107 |
| 59 | lysine catabolic process (GO:0006554) | 4.56134107 |
| 60 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.54999757 |
| 61 | plasma lipoprotein particle clearance (GO:0034381) | 4.54359059 |
| 62 | cellular ketone body metabolic process (GO:0046950) | 4.49403246 |
| 63 | glycine metabolic process (GO:0006544) | 4.43807439 |
| 64 | bile acid and bile salt transport (GO:0015721) | 4.42439331 |
| 65 | cholesterol efflux (GO:0033344) | 4.37125461 |
| 66 | imidazole-containing compound metabolic process (GO:0052803) | 4.36747903 |
| 67 | indolalkylamine metabolic process (GO:0006586) | 4.34333124 |
| 68 | coenzyme catabolic process (GO:0009109) | 4.33918801 |
| 69 | drug metabolic process (GO:0017144) | 4.32159525 |
| 70 | * acute-phase response (GO:0006953) | 4.27973492 |
| 71 | cellular amino acid catabolic process (GO:0009063) | 4.26775391 |
| 72 | glutamate metabolic process (GO:0006536) | 4.25518137 |
| 73 | amine catabolic process (GO:0009310) | 4.25418730 |
| 74 | cellular biogenic amine catabolic process (GO:0042402) | 4.25418730 |
| 75 | cellular glucuronidation (GO:0052695) | 4.23205850 |
| 76 | * negative regulation of coagulation (GO:0050819) | 4.19693151 |
| 77 | serine family amino acid metabolic process (GO:0009069) | 4.18868105 |
| 78 | plasma lipoprotein particle assembly (GO:0034377) | 4.16540598 |
| 79 | low-density lipoprotein particle remodeling (GO:0034374) | 4.13646376 |
| 80 | benzene-containing compound metabolic process (GO:0042537) | 4.11111679 |
| 81 | * negative regulation of wound healing (GO:0061045) | 4.08672313 |
| 82 | ethanol metabolic process (GO:0006067) | 4.07039828 |
| 83 | ethanol oxidation (GO:0006069) | 4.06727875 |
| 84 | cellular modified amino acid catabolic process (GO:0042219) | 4.05830833 |
| 85 | * positive regulation of hemostasis (GO:1900048) | 4.05258325 |
| 86 | * positive regulation of blood coagulation (GO:0030194) | 4.05258325 |
| 87 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.05140623 |
| 88 | arginine metabolic process (GO:0006525) | 4.04976150 |
| 89 | serine family amino acid biosynthetic process (GO:0009070) | 4.04020718 |
| 90 | oxidative demethylation (GO:0070989) | 4.02581438 |
| 91 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.00457465 |
| 92 | aldehyde catabolic process (GO:0046185) | 4.00001543 |
| 93 | phenylpropanoid metabolic process (GO:0009698) | 3.92918145 |
| 94 | drug catabolic process (GO:0042737) | 3.90586706 |
| 95 | negative regulation of complement activation (GO:0045916) | 3.90034209 |
| 96 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.89273523 |
| 97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.89273523 |
| 98 | ketone body metabolic process (GO:1902224) | 3.89032162 |
| 99 | lipoprotein metabolic process (GO:0042157) | 3.85287384 |
| 100 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.84849439 |
| 101 | phospholipid homeostasis (GO:0055091) | 3.84735689 |
| 102 | negative regulation of lipase activity (GO:0060192) | 3.84173952 |
| 103 | positive regulation of lipid catabolic process (GO:0050996) | 3.82073637 |
| 104 | cofactor catabolic process (GO:0051187) | 3.80964732 |
| 105 | cholesterol homeostasis (GO:0042632) | 3.80636503 |
| 106 | complement activation, classical pathway (GO:0006958) | 3.78432831 |
| 107 | proline metabolic process (GO:0006560) | 3.77197227 |
| 108 | plasma lipoprotein particle organization (GO:0071827) | 3.75575831 |
| 109 | complement activation (GO:0006956) | 3.75327104 |
| 110 | glucuronate metabolic process (GO:0019585) | 3.74967406 |
| 111 | uronic acid metabolic process (GO:0006063) | 3.74967406 |
| 112 | * fibrinolysis (GO:0042730) | 3.74775583 |
| 113 | sterol homeostasis (GO:0055092) | 3.74290680 |
| 114 | organic acid catabolic process (GO:0016054) | 3.73362602 |
| 115 | carboxylic acid catabolic process (GO:0046395) | 3.73362602 |
| 116 | protein-lipid complex assembly (GO:0065005) | 3.73348683 |
| 117 | regulation of bile acid biosynthetic process (GO:0070857) | 3.71226276 |
| 118 | * positive regulation of coagulation (GO:0050820) | 3.69626401 |
| 119 | * protein activation cascade (GO:0072376) | 3.66546132 |
| 120 | short-chain fatty acid metabolic process (GO:0046459) | 3.64903223 |
| 121 | sterol transport (GO:0015918) | 3.64427647 |
| 122 | cholesterol transport (GO:0030301) | 3.64427647 |
| 123 | acetyl-CoA metabolic process (GO:0006084) | 3.63796468 |
| 124 | regulation of cholesterol homeostasis (GO:2000188) | 3.63632998 |
| 125 | cytolysis (GO:0019835) | 3.63459361 |
| 126 | * blood coagulation, intrinsic pathway (GO:0007597) | 3.60108633 |
| 127 | regulation of lipoprotein particle clearance (GO:0010984) | 3.56877187 |
| 128 | opsonization (GO:0008228) | 3.55284088 |
| 129 | NAD biosynthetic process (GO:0009435) | 3.54988962 |
| 130 | negative regulation of lipid transport (GO:0032369) | 3.41794115 |
| 131 | positive regulation of steroid metabolic process (GO:0045940) | 3.39857234 |
| 132 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.29677741 |
| 133 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.29583323 |
| 134 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.29583323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.43185249 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.20921421 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.06419701 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.53593555 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.31776264 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.11823952 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.85203193 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.06839153 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.95475858 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07702218 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0561605 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95841587 |
| 13 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94676956 |
| 14 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60801805 |
| 15 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.58933549 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56563748 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55214104 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46064420 |
| 19 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41063515 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28685953 |
| 21 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20592684 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.18851425 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17938981 |
| 24 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.13558649 |
| 25 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.12265723 |
| 26 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.07835589 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.04767008 |
| 28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.01564989 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00858940 |
| 30 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99727714 |
| 31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92169903 |
| 32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91348457 |
| 33 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91241028 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86013130 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85723699 |
| 36 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83661791 |
| 37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82937005 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81471963 |
| 39 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80685735 |
| 40 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.80264467 |
| 41 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.79685824 |
| 42 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78856301 |
| 43 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77688978 |
| 44 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76884118 |
| 45 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.76541103 |
| 46 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.75889302 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75750558 |
| 48 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75403733 |
| 49 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74260668 |
| 50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71974945 |
| 51 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71047981 |
| 52 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.70707072 |
| 53 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70385872 |
| 54 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.69621382 |
| 55 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.68717768 |
| 56 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68560735 |
| 57 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.67626622 |
| 58 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67216891 |
| 59 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.66849622 |
| 60 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.66401322 |
| 61 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.66260518 |
| 62 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.65262725 |
| 63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64293700 |
| 64 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63615648 |
| 65 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63458985 |
| 66 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63458985 |
| 67 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63059760 |
| 68 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.62960899 |
| 69 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61308588 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.61075162 |
| 71 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.61056180 |
| 72 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60973867 |
| 73 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.59686695 |
| 74 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.59369968 |
| 75 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57825149 |
| 76 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.56392714 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.55646569 |
| 78 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53677938 |
| 79 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.53391664 |
| 80 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.53302113 |
| 81 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52984234 |
| 82 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51879783 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.51867299 |
| 84 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51777745 |
| 85 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51688149 |
| 86 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.51627412 |
| 87 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51024659 |
| 88 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.50988249 |
| 89 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.49929402 |
| 90 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.49924287 |
| 91 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.48933960 |
| 92 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48717892 |
| 93 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.48622644 |
| 94 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.48430776 |
| 95 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48381170 |
| 96 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.48217063 |
| 97 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.48209949 |
| 98 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48095107 |
| 99 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46638500 |
| 100 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46635601 |
| 101 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45789244 |
| 102 | GATA1_19941826_ChIP-Seq_K562_Human | 0.45054257 |
| 103 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44794117 |
| 104 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.44228547 |
| 105 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.44061641 |
| 106 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.43897819 |
| 107 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.43714572 |
| 108 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.43464586 |
| 109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.43438883 |
| 110 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.43008233 |
| 111 | TP53_16413492_ChIP-PET_HCT116_Human | 0.42367099 |
| 112 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.42310647 |
| 113 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.42236682 |
| 114 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42116700 |
| 115 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.42105056 |
| 116 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42016755 |
| 117 | GATA2_19941826_ChIP-Seq_K562_Human | 0.41031717 |
| 118 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.41029214 |
| 119 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.39879160 |
| 120 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.39347913 |
| 121 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39158113 |
| 122 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.39156223 |
| 123 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.38990954 |
| 124 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38557615 |
| 125 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.38447523 |
| 126 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38257619 |
| 127 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37689057 |
| 128 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36910378 |
| 129 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35125407 |
| 130 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.34927535 |
| 131 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.34523178 |
| 132 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33706175 |
| 133 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.33684666 |
| 134 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33632165 |
| 135 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.33270686 |
| 136 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.32210661 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.32402621 |
| 2 | MP0005360_urolithiasis | 7.51670629 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.44387009 |
| 4 | MP0005365_abnormal_bile_salt | 6.20006752 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.09003449 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.25407559 |
| 7 | MP0003252_abnormal_bile_duct | 3.88932038 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.63622506 |
| 9 | MP0009840_abnormal_foam_cell | 3.37729579 |
| 10 | MP0005083_abnormal_biliary_tract | 3.13676120 |
| 11 | MP0003195_calcinosis | 2.80855331 |
| 12 | MP0005332_abnormal_amino_acid | 2.74048224 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.59486441 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.40063092 |
| 15 | MP0003122_maternal_imprinting | 2.21473189 |
| 16 | MP0000609_abnormal_liver_physiology | 2.18094135 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.14267155 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.10885248 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.96522004 |
| 20 | MP0003868_abnormal_feces_composition | 1.92329399 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.82072613 |
| 22 | MP0001764_abnormal_homeostasis | 1.67928411 |
| 23 | MP0009697_abnormal_copulation | 1.64728321 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56730528 |
| 25 | MP0000566_synostosis | 1.53382361 |
| 26 | MP0003011_delayed_dark_adaptation | 1.46718031 |
| 27 | MP0005451_abnormal_body_composition | 1.44948016 |
| 28 | MP0001915_intracranial_hemorrhage | 1.44508872 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 1.30995271 |
| 30 | MP0003186_abnormal_redox_activity | 1.26503810 |
| 31 | MP0009643_abnormal_urine_homeostasis | 1.21658996 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.19923577 |
| 33 | MP0000598_abnormal_liver_morphology | 1.18818941 |
| 34 | MP0002089_abnormal_postnatal_growth/wei | 1.16611079 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 1.14186610 |
| 36 | MP0005647_abnormal_sex_gland | 1.13453229 |
| 37 | MP0000604_amyloidosis | 1.11117918 |
| 38 | MP0009764_decreased_sensitivity_to | 1.05847865 |
| 39 | MP0002254_reproductive_system_inflammat | 1.04610092 |
| 40 | MP0009763_increased_sensitivity_to | 1.03068903 |
| 41 | MP0010368_abnormal_lymphatic_system | 0.98442108 |
| 42 | MP0003123_paternal_imprinting | 0.93955057 |
| 43 | MP0005636_abnormal_mineral_homeostasis | 0.92733563 |
| 44 | MP0003172_abnormal_lysosome_physiology | 0.91335649 |
| 45 | MP0008469_abnormal_protein_level | 0.89103752 |
| 46 | MP0009642_abnormal_blood_homeostasis | 0.87394661 |
| 47 | MP0005408_hypopigmentation | 0.86519992 |
| 48 | MP0006036_abnormal_mitochondrial_physio | 0.81553978 |
| 49 | MP0005376_homeostasis/metabolism_phenot | 0.80163220 |
| 50 | MP0009765_abnormal_xenobiotic_induced | 0.78456475 |
| 51 | MP0005084_abnormal_gallbladder_morpholo | 0.78434968 |
| 52 | MP0002078_abnormal_glucose_homeostasis | 0.77984853 |
| 53 | MP0005670_abnormal_white_adipose | 0.77102813 |
| 54 | MP0003879_abnormal_hair_cell | 0.76338418 |
| 55 | MP0002876_abnormal_thyroid_physiology | 0.76222143 |
| 56 | MP0005220_abnormal_exocrine_pancreas | 0.73045211 |
| 57 | MP0002971_abnormal_brown_adipose | 0.71564554 |
| 58 | MP0005334_abnormal_fat_pad | 0.68916264 |
| 59 | MP0009053_abnormal_anal_canal | 0.68551827 |
| 60 | MP0001661_extended_life_span | 0.68108798 |
| 61 | MP0003690_abnormal_glial_cell | 0.68098088 |
| 62 | MP0004130_abnormal_muscle_cell | 0.67835132 |
| 63 | MP0004272_abnormal_basement_membrane | 0.66543285 |
| 64 | MP0002282_abnormal_trachea_morphology | 0.66359571 |
| 65 | MP0005535_abnormal_body_temperature | 0.65161378 |
| 66 | MP0005266_abnormal_metabolism | 0.63679419 |
| 67 | MP0003329_amyloid_beta_deposits | 0.63408263 |
| 68 | MP0000639_abnormal_adrenal_gland | 0.62512963 |
| 69 | MP0005409_darkened_coat_color | 0.61991136 |
| 70 | MP0001756_abnormal_urination | 0.57741051 |
| 71 | MP0005464_abnormal_platelet_physiology | 0.56712589 |
| 72 | MP0006035_abnormal_mitochondrial_morpho | 0.56531226 |
| 73 | MP0005448_abnormal_energy_balance | 0.55808681 |
| 74 | MP0005167_abnormal_blood-brain_barrier | 0.53565808 |
| 75 | MP0005023_abnormal_wound_healing | 0.50106999 |
| 76 | MP0002249_abnormal_larynx_morphology | 0.49955421 |
| 77 | MP0005395_other_phenotype | 0.49377856 |
| 78 | MP0009780_abnormal_chondrocyte_physiolo | 0.48143527 |
| 79 | MP0003718_maternal_effect | 0.47707406 |
| 80 | MP0002822_catalepsy | 0.47598708 |
| 81 | MP0003638_abnormal_response/metabolism_ | 0.45793886 |
| 82 | MP0005187_abnormal_penis_morphology | 0.45703580 |
| 83 | MP0002928_abnormal_bile_duct | 0.44701515 |
| 84 | MP0003567_abnormal_fetal_cardiomyocyte | 0.44602762 |
| 85 | MP0008873_increased_physiological_sensi | 0.44582203 |
| 86 | MP0008874_decreased_physiological_sensi | 0.44170159 |
| 87 | MP0005257_abnormal_intraocular_pressure | 0.44050243 |
| 88 | MP0002136_abnormal_kidney_physiology | 0.43949861 |
| 89 | MP0003436_decreased_susceptibility_to | 0.42308064 |
| 90 | MP0004782_abnormal_surfactant_physiolog | 0.41936928 |
| 91 | MP0003878_abnormal_ear_physiology | 0.41379221 |
| 92 | MP0005377_hearing/vestibular/ear_phenot | 0.41379221 |
| 93 | MP0003724_increased_susceptibility_to | 0.41005231 |
| 94 | MP0003953_abnormal_hormone_level | 0.40669094 |
| 95 | MP0003075_altered_response_to | 0.40638911 |
| 96 | MP0003632_abnormal_nervous_system | 0.40428576 |
| 97 | MP0002909_abnormal_adrenal_gland | 0.39951882 |
| 98 | MP0005248_abnormal_Harderian_gland | 0.39789488 |
| 99 | MP0004264_abnormal_extraembryonic_tissu | 0.39162070 |
| 100 | MP0002837_dystrophic_cardiac_calcinosis | 0.38873683 |
| 101 | MP0000920_abnormal_myelination | 0.37959475 |
| 102 | MP0009672_abnormal_birth_weight | 0.37426898 |
| 103 | MP0005166_decreased_susceptibility_to | 0.37090402 |
| 104 | MP0004381_abnormal_hair_follicle | 0.36704449 |
| 105 | MP0006054_spinal_hemorrhage | 0.36670648 |
| 106 | MP0008872_abnormal_physiological_respon | 0.36345438 |
| 107 | MP0005666_abnormal_adipose_tissue | 0.36295959 |
| 108 | MP0004883_abnormal_blood_vessel | 0.34229846 |
| 109 | MP0000579_abnormal_nail_morphology | 0.33923039 |
| 110 | MP0003183_abnormal_peptide_metabolism | 0.33890596 |
| 111 | MP0001243_abnormal_dermal_layer | 0.33018244 |
| 112 | MP0009115_abnormal_fat_cell | 0.32811804 |
| 113 | MP0000249_abnormal_blood_vessel | 0.32802511 |
| 114 | MP0002796_impaired_skin_barrier | 0.32732137 |
| 115 | MP0000003_abnormal_adipose_tissue | 0.32141535 |
| 116 | MP0001324_abnormal_eye_pigmentation | 0.31615883 |
| 117 | MP0006082_CNS_inflammation | 0.30961518 |
| 118 | MP0001853_heart_inflammation | 0.30663508 |
| 119 | MP0003121_genomic_imprinting | 0.30526896 |
| 120 | MP0003566_abnormal_cell_adhesion | 0.30515064 |
| 121 | MP0009384_cardiac_valve_regurgitation | 0.30416554 |
| 122 | MP0002168_other_aberrant_phenotype | 0.30227950 |
| 123 | MP0002970_abnormal_white_adipose | 0.30206189 |
| 124 | MP0000230_abnormal_systemic_arterial | 0.29804729 |
| 125 | MP0002933_joint_inflammation | 0.29119068 |
| 126 | MP0001881_abnormal_mammary_gland | 0.28467385 |
| 127 | MP0002128_abnormal_blood_circulation | 0.28171392 |
| 128 | MP0001845_abnormal_inflammatory_respons | 0.27954397 |
| 129 | MP0000858_altered_metastatic_potential | 0.27743964 |
| 130 | MP0005410_abnormal_fertilization | 0.26991461 |
| 131 | MP0005164_abnormal_response_to | 0.26503090 |
| 132 | MP0003943_abnormal_hepatobiliary_system | 0.26496819 |
| 133 | MP0002132_abnormal_respiratory_system | 0.25839484 |
| 134 | MP0002090_abnormal_vision | 0.23595201 |
| 135 | MP0002060_abnormal_skin_morphology | 0.23343175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.44277760 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.36211099 |
| 3 | * Deep venous thrombosis (HP:0002625) | 7.01116575 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.72748483 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.58390019 |
| 6 | Xanthomatosis (HP:0000991) | 6.37908244 |
| 7 | * Prolonged partial thromboplastin time (HP:0003645) | 6.18138741 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.66042069 |
| 9 | Complement deficiency (HP:0004431) | 5.42483327 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.95083496 |
| 11 | Hyperammonemia (HP:0001987) | 4.64098214 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.61852314 |
| 13 | Epidermoid cyst (HP:0200040) | 4.54904690 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.52348092 |
| 15 | Hyperglycinemia (HP:0002154) | 4.44669793 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.33219287 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.33015320 |
| 18 | Ketosis (HP:0001946) | 4.26573420 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.26427805 |
| 20 | * Joint hemorrhage (HP:0005261) | 4.20639224 |
| 21 | Fat malabsorption (HP:0002630) | 4.16062728 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.14663739 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.14618317 |
| 24 | Abnormality of complement system (HP:0005339) | 3.95900209 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.92274512 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.92274512 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.91996567 |
| 28 | Hyperglycinuria (HP:0003108) | 3.91445958 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.88178885 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.85936769 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.75619480 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.70840939 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.40575870 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.37191862 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.33539650 |
| 36 | Spontaneous abortion (HP:0005268) | 3.19416559 |
| 37 | Purpura (HP:0000979) | 3.15945296 |
| 38 | Steatorrhea (HP:0002570) | 3.11127326 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.08996607 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.08955071 |
| 41 | Hypochromic microcytic anemia (HP:0004840) | 3.08138729 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.05974389 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 3.03396426 |
| 44 | Ketoacidosis (HP:0001993) | 3.00575714 |
| 45 | Myocardial infarction (HP:0001658) | 2.96459497 |
| 46 | Skin nodule (HP:0200036) | 2.80332368 |
| 47 | Metabolic acidosis (HP:0001942) | 2.76786321 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.73978412 |
| 49 | Acanthocytosis (HP:0001927) | 2.72653854 |
| 50 | * Menorrhagia (HP:0000132) | 2.66477978 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.64872141 |
| 52 | Osteomalacia (HP:0002749) | 2.61654350 |
| 53 | Lethargy (HP:0001254) | 2.60946713 |
| 54 | Vascular calcification (HP:0004934) | 2.59617126 |
| 55 | Dicarboxylic aciduria (HP:0003215) | 2.57290303 |
| 56 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.57290303 |
| 57 | Hypoglycemic seizures (HP:0002173) | 2.55023714 |
| 58 | Glomerulonephritis (HP:0000099) | 2.55001415 |
| 59 | Abnormal gallbladder morphology (HP:0012437) | 2.53401359 |
| 60 | Abnormal gallbladder physiology (HP:0012438) | 2.47881658 |
| 61 | Cholecystitis (HP:0001082) | 2.47881658 |
| 62 | Cholelithiasis (HP:0001081) | 2.47271637 |
| 63 | Spastic diplegia (HP:0001264) | 2.45854157 |
| 64 | Cerebral edema (HP:0002181) | 2.43084216 |
| 65 | Mitral stenosis (HP:0001718) | 2.42123209 |
| 66 | Amyloidosis (HP:0011034) | 2.40838149 |
| 67 | Gout (HP:0001997) | 2.39398212 |
| 68 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.36617916 |
| 69 | Irritability (HP:0000737) | 2.35729802 |
| 70 | Neonatal onset (HP:0003623) | 2.34147121 |
| 71 | Arthropathy (HP:0003040) | 2.30662001 |
| 72 | Cardiovascular calcification (HP:0011915) | 2.30034264 |
| 73 | Malnutrition (HP:0004395) | 2.26629155 |
| 74 | Esophageal varix (HP:0002040) | 2.26308399 |
| 75 | Abnormality of carpal bone ossification (HP:0006257) | 2.19027050 |
| 76 | Abnormal tarsal ossification (HP:0008369) | 2.17623398 |
| 77 | Abnormality of the Achilles tendon (HP:0005109) | 2.15070678 |
| 78 | Pancreatitis (HP:0001733) | 2.15056776 |
| 79 | Poikilocytosis (HP:0004447) | 2.14721880 |
| 80 | Brushfield spots (HP:0001088) | 2.14094287 |
| 81 | Late onset (HP:0003584) | 2.14008831 |
| 82 | Enlarged kidneys (HP:0000105) | 2.12996253 |
| 83 | Sensorimotor neuropathy (HP:0007141) | 2.12320244 |
| 84 | Vomiting (HP:0002013) | 2.06457309 |
| 85 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.05846055 |
| 86 | Abnormality of the gallbladder (HP:0005264) | 2.04956955 |
| 87 | Increased serum pyruvate (HP:0003542) | 2.03843703 |
| 88 | Hemorrhage of the eye (HP:0011885) | 2.03293832 |
| 89 | Opisthotonus (HP:0002179) | 2.02285877 |
| 90 | Generalized aminoaciduria (HP:0002909) | 2.01490025 |
| 91 | Abnormality of iron homeostasis (HP:0011031) | 1.94599947 |
| 92 | Bifid scrotum (HP:0000048) | 1.94271994 |
| 93 | Rickets (HP:0002748) | 1.94105188 |
| 94 | Reduced antithrombin III activity (HP:0001976) | 1.93001404 |
| 95 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91663193 |
| 96 | Abnormal cartilage morphology (HP:0002763) | 1.87860338 |
| 97 | Renal cortical cysts (HP:0000803) | 1.86586959 |
| 98 | Hypophosphatemic rickets (HP:0004912) | 1.86534061 |
| 99 | * Thrombophlebitis (HP:0004418) | 1.85640449 |
| 100 | Facial shape deformation (HP:0011334) | 1.85508385 |
| 101 | Potter facies (HP:0002009) | 1.85508385 |
| 102 | Joint swelling (HP:0001386) | 1.83610326 |
| 103 | Abnormality of proline metabolism (HP:0010907) | 1.83167093 |
| 104 | Hydroxyprolinuria (HP:0003080) | 1.83167093 |
| 105 | Elevated hepatic transaminases (HP:0002910) | 1.82180592 |
| 106 | Abnormality of glycolysis (HP:0004366) | 1.81553339 |
| 107 | Alkalosis (HP:0001948) | 1.81101966 |
| 108 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80724486 |
| 109 | * Gingival bleeding (HP:0000225) | 1.80524987 |
| 110 | Nephritis (HP:0000123) | 1.80400188 |
| 111 | Gangrene (HP:0100758) | 1.78943664 |
| 112 | Status epilepticus (HP:0002133) | 1.78431601 |
| 113 | Hyperglycemia (HP:0003074) | 1.75615229 |
| 114 | Abnormal delivery (HP:0001787) | 1.75109369 |
| 115 | Reticulocytosis (HP:0001923) | 1.74513540 |
| 116 | Abnormality of vitamin metabolism (HP:0100508) | 1.74256332 |
| 117 | Fair hair (HP:0002286) | 1.74038785 |
| 118 | Vaginal fistula (HP:0004320) | 1.72108115 |
| 119 | Increased serum ferritin (HP:0003281) | 1.71224451 |
| 120 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.71107295 |
| 121 | * Pulmonary embolism (HP:0002204) | 1.66831241 |
| 122 | Asymmetry of the thorax (HP:0001555) | 1.65946947 |
| 123 | Flat acetabular roof (HP:0003180) | 1.65392704 |
| 124 | Broad alveolar ridges (HP:0000187) | 1.64367494 |
| 125 | Elevated alkaline phosphatase (HP:0003155) | 1.63955633 |
| 126 | Hyperphosphaturia (HP:0003109) | 1.63617497 |
| 127 | Glycosuria (HP:0003076) | 1.59222233 |
| 128 | Abnormality of urine glucose concentration (HP:0011016) | 1.59222233 |
| 129 | Abnormal hand bone ossification (HP:0010660) | 1.58004908 |
| 130 | Retinal atrophy (HP:0001105) | 1.57878756 |
| 131 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.56676946 |
| 132 | Abnormality of the lumbar spine (HP:0100712) | 1.55906904 |
| 133 | Abnormal ossification of hand bones (HP:0005921) | 1.55430000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.15763742 |
| 2 | FGFR4 | 4.64295580 |
| 3 | SIK1 | 4.60190898 |
| 4 | ERN1 | 4.33950905 |
| 5 | TAOK3 | 3.17442085 |
| 6 | INSRR | 3.03868730 |
| 7 | WNK4 | 2.98991792 |
| 8 | ERBB4 | 2.93316735 |
| 9 | CDK12 | 2.56232312 |
| 10 | MAP2K4 | 2.33568216 |
| 11 | PKN2 | 2.26627759 |
| 12 | MST1R | 2.14311944 |
| 13 | FLT3 | 1.96336339 |
| 14 | MAPK11 | 1.91835519 |
| 15 | TYRO3 | 1.90474539 |
| 16 | PIK3CG | 1.87414271 |
| 17 | PDGFRA | 1.85564621 |
| 18 | FGFR1 | 1.81781141 |
| 19 | TRIB3 | 1.74524995 |
| 20 | TYK2 | 1.73379186 |
| 21 | LATS1 | 1.67084972 |
| 22 | DAPK2 | 1.63142466 |
| 23 | AKT3 | 1.60944125 |
| 24 | ABL2 | 1.48604321 |
| 25 | PTK6 | 1.47281700 |
| 26 | NEK9 | 1.45209118 |
| 27 | FGFR2 | 1.37520452 |
| 28 | FRK | 1.35696805 |
| 29 | KDR | 1.34255274 |
| 30 | WNK1 | 1.23771884 |
| 31 | JAK2 | 1.23195241 |
| 32 | NTRK3 | 1.17832683 |
| 33 | MAP3K7 | 1.17303701 |
| 34 | SIK2 | 1.16925977 |
| 35 | MAP3K2 | 1.16433106 |
| 36 | PINK1 | 1.13035193 |
| 37 | PRKAA2 | 1.12875700 |
| 38 | EIF2AK1 | 1.12060712 |
| 39 | PDK2 | 1.11735976 |
| 40 | GRK6 | 1.07919888 |
| 41 | MAP2K3 | 1.07456629 |
| 42 | ERBB2 | 1.03316100 |
| 43 | TBK1 | 1.02743048 |
| 44 | JAK1 | 1.02411957 |
| 45 | EEF2K | 1.00876411 |
| 46 | MAPK4 | 0.99340896 |
| 47 | MAP3K10 | 0.98547770 |
| 48 | MAP3K14 | 0.95803143 |
| 49 | PRKCZ | 0.90989230 |
| 50 | DDR2 | 0.88386378 |
| 51 | MAP3K3 | 0.87780754 |
| 52 | MET | 0.87434408 |
| 53 | STK38L | 0.85212529 |
| 54 | EPHB1 | 0.84006750 |
| 55 | MAPKAPK3 | 0.82863832 |
| 56 | CDK6 | 0.81706613 |
| 57 | EPHA3 | 0.81259574 |
| 58 | MAP3K11 | 0.80462649 |
| 59 | MAPK12 | 0.80373917 |
| 60 | MAPK15 | 0.78848448 |
| 61 | TIE1 | 0.77939302 |
| 62 | PRKACG | 0.77393128 |
| 63 | CSNK1E | 0.75861695 |
| 64 | CDK7 | 0.74610109 |
| 65 | SGK1 | 0.74072482 |
| 66 | CAMK2G | 0.71658443 |
| 67 | DYRK1B | 0.71330403 |
| 68 | CAMK1D | 0.70746799 |
| 69 | CSK | 0.69530230 |
| 70 | GSK3A | 0.67443783 |
| 71 | PRKAA1 | 0.66096798 |
| 72 | MAP2K6 | 0.65597036 |
| 73 | RPS6KB1 | 0.63101206 |
| 74 | SGK3 | 0.62947806 |
| 75 | RIPK1 | 0.61769845 |
| 76 | IRAK3 | 0.59755758 |
| 77 | EPHA2 | 0.58964909 |
| 78 | TGFBR2 | 0.58423746 |
| 79 | CSNK1D | 0.58085914 |
| 80 | MAPK7 | 0.57453116 |
| 81 | FGFR3 | 0.56997509 |
| 82 | FGR | 0.56779408 |
| 83 | CSF1R | 0.56519134 |
| 84 | PTK2 | 0.56165859 |
| 85 | SMG1 | 0.55030129 |
| 86 | KSR2 | 0.54822721 |
| 87 | IKBKE | 0.52838006 |
| 88 | CDC42BPA | 0.51564620 |
| 89 | PRKCQ | 0.50631518 |
| 90 | PDPK1 | 0.48770779 |
| 91 | PRKG1 | 0.47850277 |
| 92 | CSNK1G1 | 0.47510287 |
| 93 | TAOK2 | 0.47282920 |
| 94 | SGK2 | 0.46555627 |
| 95 | MAP3K5 | 0.46116167 |
| 96 | GRK1 | 0.45988277 |
| 97 | NLK | 0.45633223 |
| 98 | EPHA4 | 0.45465704 |
| 99 | CSNK2A2 | 0.45103786 |
| 100 | MAP2K1 | 0.44734494 |
| 101 | IGF1R | 0.43921440 |
| 102 | BRSK1 | 0.43118326 |
| 103 | NEK1 | 0.43052977 |
| 104 | CDK4 | 0.42585290 |
| 105 | SRC | 0.42370589 |
| 106 | RET | 0.42082132 |
| 107 | PRKCG | 0.42002095 |
| 108 | RPS6KA3 | 0.40962068 |
| 109 | CSNK2A1 | 0.40448285 |
| 110 | MAP3K13 | 0.40074212 |
| 111 | MAP3K6 | 0.38759797 |
| 112 | ICK | 0.38641678 |
| 113 | BCR | 0.38231403 |
| 114 | PKN1 | 0.37986368 |
| 115 | BRSK2 | 0.36936253 |
| 116 | PBK | 0.36058097 |
| 117 | MTOR | 0.35876394 |
| 118 | MATK | 0.35249473 |
| 119 | PRKACA | 0.34607526 |
| 120 | EGFR | 0.33294953 |
| 121 | SGK223 | 0.32874244 |
| 122 | SGK494 | 0.32874244 |
| 123 | CAMK4 | 0.31771068 |
| 124 | PRKCB | 0.31460498 |
| 125 | PDK1 | 0.30261053 |
| 126 | PRKACB | 0.29787291 |
| 127 | MAP3K1 | 0.29028232 |
| 128 | CSNK1G2 | 0.27341553 |
| 129 | CDK9 | 0.26657921 |
| 130 | CDK8 | 0.26545032 |
| 131 | PRKCA | 0.25608438 |
| 132 | LATS2 | 0.25240790 |
| 133 | BRD4 | 0.24727786 |
| 134 | NEK2 | 0.24517758 |
| 135 | CSNK1G3 | 0.23506249 |
| 136 | IRAK1 | 0.22512452 |
| 137 | MAP2K2 | 0.22308668 |
| 138 | CAMK1G | 0.21278570 |
| 139 | PIK3CA | 0.21203146 |
| 140 | PAK3 | 0.20704063 |
| 141 | ABL1 | 0.20547799 |
| 142 | IRAK2 | 0.19074288 |
| 143 | MAPK3 | 0.18773527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.50836828 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.66829523 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39084598 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.35553726 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.09162431 |
| 6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.76370539 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.71652058 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66850392 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63191135 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55421195 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48467514 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37039690 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23892794 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14561506 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.13345848 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.06352282 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94841837 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92273861 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91643247 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91376420 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90499541 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86936903 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81325871 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80299134 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76362128 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74985701 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70925846 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69793914 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68789772 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65316321 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61990699 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58477975 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55966968 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50925138 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50455416 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.48274798 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43779642 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35789805 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34134880 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33387200 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32183630 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27791940 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22466169 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21190657 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.20493172 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20405817 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19410625 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12995776 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02117719 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02003569 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00673969 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98388865 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97883814 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96690353 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93743476 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88322784 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87440266 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82176691 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.81209112 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78021952 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70540069 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67599333 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66357174 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65105066 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59030580 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54468261 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45826086 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45768740 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.45141310 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41730382 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.35035062 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26303549 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25887706 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24430994 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.22903219 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.22052484 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21979343 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21439251 |
| 79 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.18920623 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15794779 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09663452 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.08029678 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01812222 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.00608928 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | -0.2452470 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | -0.2450822 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2437263 |
| 88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2383659 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2329127 |
| 90 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.2053329 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1989151 |
| 92 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1901446 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1897473 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1878510 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | -0.1755909 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1671173 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | -0.1629528 |
| 98 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1625100 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1616428 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1592047 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1405050 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1352708 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1204752 |
| 104 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.1067503 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1009420 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0849411 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0707019 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0654823 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0486204 |

